105 results
Page 5 of 6
10-K
EX-31.1
279ubm zyfgif8feyi
31 Mar 21
Annual report
4:30pm
8-K
EX-10.2
a5uhaup9yh2 m8clw
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
UPLOAD
zco cgcbcyej9km6s44
3 Feb 21
Letter from SEC
12:00am
S-3
EX-4.4
9msi6nmjy
29 Jan 21
Shelf registration
4:48pm
S-3
pdcfewx
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
ro1 bqmj47gxwig
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
wk8srj7
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
beykdy 6q9jvd9uxgg
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
6pzl x64wkie
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.2
do66ke7w8b30 u5d
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
yoysr udhgfqlas
2 Nov 20
Prospectus supplement
12:00am